Philipp Kruppa1, Iakovos Georgiou, Niklas Biermann, Lukas Prantl, Peter Klein-Weigel, Mojtaba Ghods. 1. Department of Plastic, Aesthetic, Hand and Reconstructive Micro Surgery, Klinikum Ernst von Bergmann, Potsdam; Department of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg; Department of Angiology, Klinikum Ernst von Bergmann, Potsdam.
Abstract
BACKGROUND: Lipedema is often unrecognized or misdiagnosed; despite an estimated prevalence of 10% in the overall female population, its cause is still unknown. There is increasing awareness of this condition, but its differential diagnosis can still be challenging. In this article, we summarize current hypotheses on its pathogenesis and the recommendations of current guidelines for its diagnosis and treatment. METHODS: This review is based on publications about lipedema that were retrieved by a selective search in the MEDLINE, Web of Science, and Cochrane Library databases. RESULTS: The pathophysiology of lipedema remains unclear. The putative causes that have been proposed include altered adipogenesis, microangiopathy, and disturbed lymphatic microcirculation. No specific biomarker has yet been found, and the diagnosis is currently made on clinical grounds alone. Ancillary tests are used only to rule out competing diagnoses. The state of the evidence on treatment is poor. Treatment generally consists of complex decongestive therapy. In observational studies, liposuction for the permanent reduction of adipose tissue has been found to relieve symptoms to a significant extent, with only rare complications. The statutory healthinsurance carriers in Germany do not yet regularly cover the cost of the procedure; studies of high methodological quality will be needed before this is the case. CONCLUSION: The diagnosis of lipedema remains a challenge because of the hetero - geneous presentation of the condition and the current lack of objective measuring instruments to characterize it. This review provides a guide to its diagnosis and treatment in an interdisciplinary setting. Research in this area should focus on the elucidation of the pathophysiology of lipedema and the development of a specific biomarker for it.
BACKGROUND:Lipedema is often unrecognized or misdiagnosed; despite an estimated prevalence of 10% in the overall female population, its cause is still unknown. There is increasing awareness of this condition, but its differential diagnosis can still be challenging. In this article, we summarize current hypotheses on its pathogenesis and the recommendations of current guidelines for its diagnosis and treatment. METHODS: This review is based on publications about lipedema that were retrieved by a selective search in the MEDLINE, Web of Science, and Cochrane Library databases. RESULTS: The pathophysiology of lipedema remains unclear. The putative causes that have been proposed include altered adipogenesis, microangiopathy, and disturbed lymphatic microcirculation. No specific biomarker has yet been found, and the diagnosis is currently made on clinical grounds alone. Ancillary tests are used only to rule out competing diagnoses. The state of the evidence on treatment is poor. Treatment generally consists of complex decongestive therapy. In observational studies, liposuction for the permanent reduction of adipose tissue has been found to relieve symptoms to a significant extent, with only rare complications. The statutory healthinsurance carriers in Germany do not yet regularly cover the cost of the procedure; studies of high methodological quality will be needed before this is the case. CONCLUSION: The diagnosis of lipedema remains a challenge because of the hetero - geneous presentation of the condition and the current lack of objective measuring instruments to characterize it. This review provides a guide to its diagnosis and treatment in an interdisciplinary setting. Research in this area should focus on the elucidation of the pathophysiology of lipedema and the development of a specific biomarker for it.
Authors: Anne H Child; Kristiana D Gordon; Pip Sharpe; Glen Brice; Pia Ostergaard; Steve Jeffery; Peter S Mortimer Journal: Am J Med Genet A Date: 2010-04 Impact factor: 2.802
Authors: Paula M C Donahue; Rachelle Crescenzi; Kalen J Petersen; Maria Garza; Niral Patel; Chelsea Lee; Sheau-Chiann Chen; Manus J Donahue Journal: Lymphat Res Biol Date: 2021-11-08 Impact factor: 2.349
Authors: Karin Strohmeier; Martina Hofmann; Jaroslaw Jacak; Marie-Sophie Narzt; Marlene Wahlmueller; Mario Mairhofer; Barbara Schaedl; Wolfgang Holnthoner; Martin Barsch; Matthias Sandhofer; Susanne Wolbank; Eleni Priglinger Journal: Biomedicines Date: 2022-05-18
Authors: John C Rasmussen; Melissa B Aldrich; Caroline E Fife; Karen L Herbst; Eva M Sevick-Muraca Journal: Obesity (Silver Spring) Date: 2022-06-15 Impact factor: 9.298
Authors: Roberto Cannataro; Sandro Michelini; Lorenzo Ricolfi; Maria Cristina Caroleo; Luca Gallelli; Giovambattista De Sarro; Alberto Onorato; Erika Cione Journal: Life (Basel) Date: 2021-12-15